Kala Bio KALA Cash Flow Statement (2016-2026)

NASDAQ KALA
$0.42 -0.01 (-2.77%)
As of: Oct 1, 2026 · 2:27 PM EDT
Reported Financials

Kala Bio Quarterly Cash Flow Statement

Periods 41 quarters
Latest Jun 2026

Kala Bio reported cash from operations of -$1.53M and free cash flow of -$1.53M for the quarter ended Jun 2026, up 90.7% year over year. This cash flow statement covers 41 quarters of results from Jun 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-28.13M-48.88M-32.94M-28.11M-15.78M-11.47M-12.48M-10.29M-9.51M-10.48M-12.88M-10.56M-10.90M-10.37M-11.30M-11.70M-7.93M-10.37M-1.73M-1.58M
Depreciation and Depletion
Share-based Compensation
3.93M2.75M2.81M1.92M1.33M0.96M1.32M1.36M2.40M2.37M2.38M1.88M2.04M2.09M2.31M2.24M2.04M0.40M1.75M
Gains from Sales and Divestitures
46.99M
Asset Writedowns and Impairment
1.41M
Cash from Operations
-26.08M-27.90M-24.09M-25.42M-15.66M-13.73M-9.68M-7.59M-2.95M-7.70M-10.84M-9.21M-4.72M-4.60M-8.82M-16.56M-10.88M-4.56M-2.90M-1.53M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization
0.26M0.21M0.16M0.15M0.15M0.08M0.08M0.08M0.08M0.07M0.07M0.06M0.06M0.07M0.07M0.07M0.13M0.05M
Change in Working Capital
Change in Receivables
0.77M2.73M-2.33M0.80M-13.62M0.01M-0.08M0.00M
Change in Inventory
1.39M-0.52M0.16M1.42M-0.57M-2.72M-2.19M-0.11M-5.24M
Change in Account Payables
3.00M-1.02M1.22M4.42M-3.21M-4.51M-1.83M-0.24M0.03M0.13M-0.19M-0.07M0.05M-0.08M0.30M-0.27M0.26M0.07M0.06M0.10M
Change in Accured Expenses
-1.47M1.22M0.33M-3.00M7.20M-16.46M-4.49M-0.16M4.33M-2.10M-2.16M1.14M-1.24M0.74M-0.88M-0.71M-0.98M-1.31M-0.99M-0.12M
Other Working Capital Changes
2.06M1.62M-1.66M-1.80M20.39M-14.92M-5.47M-1.27M0.77M0.14M-0.38M3.05M-2.57M-0.46M1.88M-1.77M1.46M-1.25M1.62M-0.20M
Investing Activities
Capital Expenditures
0.33M0.01M0.08M0.17M0.04M0.02M0.11M0.21M0.28M0.01M0.01M0.04M0.09M0.07M-0.00M
Sales of Property, Plant and Equipment
0.04M0.07M
Cash from Investing Activities
4.72M-4.62M-5.07M2.83M64.91M0.05M-0.11M-10.03M9.72M-0.01M-0.01M-0.04M-0.09M-0.07M0.00M-7.00M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Issuances
Long-Term Debt Repayments
0.01M0.01M0.01M0.01M0.01M0.01M0.03M0.03M0.03M0.03M0.00M
Change in Capital Stock
Net Preferred Shares Issued and Repurchased
8.54M
Net Equity Issued and Repurchased
0.33M0.17M0.16M0.14M0.73M14.89M3.07M0.57M0.02M-2.49M4.94M0.92M0.01M0.06M9.06M4.10M
Misc.
Cash from Financing Activities
1.23M0.16M0.15M-0.01M-39.87M31.79M2.86M3.07M0.04M2.54M8.44M14.97M-0.18M6.65M-0.14M-2.53M0.03M-8.98M4.10M
Change in Cash
-20.13M-32.37M-29.01M-22.60M9.37M18.10M-6.93M-14.55M6.81M-5.17M-2.42M5.72M-5.00M1.98M-8.96M-10.28M-10.85M-13.54M-5.79M-1.53M
Free Cash Flow
-26.41M-27.92M-24.17M-25.59M-15.70M-13.76M-9.79M-7.81M-3.23M-7.70M-10.86M-9.25M-4.82M-4.67M-8.82M-16.56M-10.88M-4.56M-2.90M-1.53M
Net Cash Flow
-20.13M-32.37M-29.01M-22.60M9.37M18.10M-6.93M-14.55M6.81M-5.17M-2.42M5.72M-5.00M1.98M-8.96M-19.09M-10.85M-13.54M-5.79M-1.53M

Kala Bio Cash Flow Statement API

Pull Kala Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=KALA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY